Related Experiment Video
Updated: May 9, 2026

Tissue-specific miRNA Expression Profiling in Mouse Heart Sections Using In Situ Hybridization
Published on: September 15, 2018
MicroRNAs in heart failure: new targets in disease management
I Elzenaar1, Y M Pinto, R J van Oort
1Department of Experimental Cardiology, Academic Medical Center, Amsterdam, The Netherlands.
Abstract:
Heart failure is the leading cause of mortality in Western society and represents the fastest growing subclass of cardiovascular diseases. An increasing body of evidence indicates an important role for microRNAs (miRNAs) in the pathogenesis and progression of heart failure. miRNAs are small noncoding RNAs that regulate expression of target genes by sequence-specific binding to the 3' untranslated region of messenger RNA, which results in degradation or translational repression. To date, many miRNAs (and their targets) that play a role in diverse aspects of cardiac remodeling and heart failure development have been identified. Here, we give an overview of these miRNAs and their role in cardiac pathogenesis. In addition, we provide brief insight into the potential of miRNAs as novel therapeutic targets for heart failure.
Related Concept Videos
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Heart Failure V: Medical Management
Heart Failure II: Pathophysiology
Mitral Regurgitation IV: Nursing Management
Cardiomyopathy V: Interprofessional Care
Rheumatic Heart Disease III: Medical Management